Oncology

Targeted therapies for cancer treatment 

Cancer is the second leading cause of death globally behind cardiovascular disease. The cancer burden continues to grow globally, exerting tremendous physical, emotional and financial strain on individuals, families, communities and health systems. Developing new and effective therapeutic approaches in this complex setting remains a challenge.  

A crosshair is aimed at a cancer cell located next to normal cells

Oncology services from target discovery to the clinic 

Our oncology team of scientists provides top-tier pharmacology services spanning from preclinical and translational science to clinical development. With extensive industry experience across various drug targets and modalities, we are skilled in establishing and executing innovative mechanistic cellular and in vivo assays. Leveraging our broad range of models, we delve deeply into the biology of drug development programs to uncover the molecular drivers of efficacy. Our team collaborates closely with you to design, support and deliver customised pharmacology studies that align with your specific objectives. 

Biomarker scientists performing immunohistochemistry

Our oncology services at a glance 

At Nuvisan, our team of highly experienced scientists and staff bring over a decade of pharmaceutical industry expertise and a proven track record in successfully advancing drug discovery programs into clinical stages. They will provide your project with deep knowledge across a wide range of oncology areas and treatment modalities. We leverage state-of-the-art in vitro and in vivo facilities, fully equipped to support every phase of drug discovery and development. 

Our capabilities/platform services include:  

  • Comprehensive cancer model collection  
  • Target validation 
  • Customised model and assay generation  
  • In vivo facility: efficacy, PK/PD and biomarker studies
  • DMPK studies 
  • Next-generation and single-cell sequencing
  • Bioinformatics services
  • CRISPR/RNAi platform
  • Gene and protein expression
  • Multiplex flow cytometry
  • Biomarker discovery and assay development
  • Clinical translation of biomarkers
  • Tissue biobank. 

Related topics & resources

Illustrative visualization of immune cells, e.g. T cells, launching an attack on a cancer cell

In vivo oncology models

Find out how we can support your with our in vivo oncology models. 

learn more about In vivo oncology models
An artistic depiction of an antibody binding to a cell-surface protein

Immuno-oncology models

We offer a variety of immune-oncology models for your discovery efforts. 

learn more about Immuno-oncology models
Cell partitioning and barcoding for single-cell sequencing are performed on a chip

Target ID, validation & deconvolution

Explore our target discovery capabilities supporting your drug discovery and development projects.  

learn more about Target ID, validation & deconvolution

Contact us

Nuvisan is committed to protecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Email us

hello@nuvisan.com

Talk to us

talk icon
+49 731 9840 0 

Our locations

location icon

Neu-Ulm (headquarters)

Wegenerstrasse 13

89231 Neu-Ulm

Germany

Berlin

Muellerstrasse 178

13353 Berlin

Germany

Sophia Antipolis

2400 route des Colles

06410 Biot

France

Grafing

Am Feld 32

85567 Grafing

Germany

Waltrop

Im Wirrigen 25

45731 Waltrop

Germany

For concerns about pharmaceuticals or adverse drug-related events, contact us at: complaints@nuvisan.com